Niagen Bioscience, Inc. — Director's Dealing 2014

Jun 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2014-06-18

Reporting Person: Allen Stephen R. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-18	Employee Stock Options (right to buy)	$1.25	A	82500	Acquired	2024-06-18	Common Stock (82500)	Direct

Footnotes

F1: Options vest 1/12th every month for 12 months and will be fully vested on June 18, 2015.

F2: The total includes 200,000 options under different terms.